ArticleMolecular cancer therapeutics2024

Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma.

Victor J Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.